A national survey of the Infectious Diseases Society of America Emerging Infections Network concerning neuraminidase inhibitor prescription practices and pandemic influenza preparations

Clin Infect Dis. 2006 Aug 15;43(4):494-7. doi: 10.1086/505975. Epub 2006 Jul 11.

Abstract

This report summarizes the findings of a national survey of infectious diseases consultants regarding their use of neuraminidase inhibitors and the status of their planning for an influenza pandemic. The respondents indicated that government stockpiles should be increased, that many have received requests for antiviral medications, and that additional recommendations regarding the appropriate use of antiviral medications would be helpful.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antiviral Agents / therapeutic use
  • Communicable Diseases*
  • Communicable Diseases, Emerging
  • Cross-Sectional Studies
  • Disease Outbreaks
  • Enzyme Inhibitors / therapeutic use*
  • Health Care Surveys
  • Health Planning
  • Humans
  • Influenza, Human / drug therapy*
  • Neuraminidase / antagonists & inhibitors
  • Practice Patterns, Physicians'*
  • Societies, Medical*
  • United States

Substances

  • Antiviral Agents
  • Enzyme Inhibitors
  • Neuraminidase